(Q53259579)

English

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

0 references

author name string

O'Shea D

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Giles C

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Terpos E

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Perz J

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Politou M

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Sana V

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Naresh K

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Lampert I

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Samson D

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Narat S

10

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Kanfer E

11

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Olavarria E

12

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Apperley JF

13

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Rahemtulla A

14

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Bone Marrow Transplantation

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

37

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

731-737

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705307

0 references

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705307

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705307

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16501593

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53259579&oldid=1465432222"